Valeant Pharmaceuticals Intl Inc. Is at the Mercy of its Lenders

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is trying to get its debt covenants relaxed. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) has shown that this can be painful.

| More on:
The Motley Fool

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in danger of defaulting on its debt, which would be yet another catastrophe for shareholders. To save itself from that fate, it is currently negotiating with its lenders to ease covenants.

But this has consequences too, as has been demonstrated by a number of oil companies. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) is one example. We’ll take a closer look below.

Valeant’s covenants

According to Valeant’s credit agreement, a default will occur if Valeant doesn’t file its 10-K (which includes audited financial statements) by the end of this month. In that scenario, Valeant will then have 30 days to cure the default by filing its 10-K.

Meanwhile, Valeant has already breached the reporting covenant in its bond indentures, which required a 10-K by March 16. As a result, the company is restricted from borrowing any more money from its revolver.

These aren’t the only covenants Valeant must adhere to; there are also certain financial targets that the company must maintain. The company said it expects to be in compliance with all covenants this year and next, but until the company releases audited financials, it’s impossible to know for sure.

Penn West’s experience

At the beginning of last year Penn West was about to breach its debt covenants, which would have meant a default. To avoid such a fate, the company got lenders to relax covenants. And even though an agreement was reached, it was not a fun process.

For starters, Penn West had to lower its quarterly dividend from $0.03 to $0.01. The company also had to cancel a $500 million tranche in its bank facility. It also had to grant floating charge security over all its property. If that wasn’t bad enough, Penn West had to pledge that any asset sales would go towards reducing debt. To top it all off, the company had to agree to higher interest payments.

Anything can happen

This situation with Valeant is a little different, because Valeant hasn’t even released audited financials, making the outcome very unpredictable. Otherwise, Penn West’s experience provides a useful learning experience.

And anonymous sources have already told Reuters that “creditors prepare to slam company with tougher demands” in exchange for relaxing covenants. So one way or another, Valeant is in for a rough ride. This story is far from over.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

Young adult woman walking up the stairs with sun sport background
Dividend Stocks

Beginning Investors: 3 TSX Stocks I’d Buy With $500 Right Now

These TSX stocks are easy to follow and high-quality companies you can commit to owning long term, making them some…

Read more »

Person holds banknotes of Canadian dollars
Dividend Stocks

TFSA Passive Income: Earn Over $600 Per Month

Here's how Canadian investors can use the TFSA to create a steady and recurring passive-income stream for life.

Read more »

grow dividends
Dividend Stocks

2 Top TSX Dividend Stocks With Huge Upside Potential

These top dividend stocks could go much higher in 2025.

Read more »

Canadian Red maple leaves seamless wallpaper pattern
Dividend Stocks

Canadian Tire is Paying $7 per Share in Dividends – Time to Buy the Stock?

Canadian Tire stock (TSX:CTC.A) has one of the best dividends in the business, with a dividend at $7 per year.…

Read more »

gaming, tech
Tech Stocks

Should You Load Up on Spotify Stock?

Spotify shares (NYSE:SPOT) surged on earnings, leaving investors to wonder whether they've missed the boat on this growth stock.

Read more »

edit Sale sign, value, discount
Investing

3 Growth Stocks Available at a Great Discount

Given their healthy long-term growth prospects and discounted stock prices, these three stocks look like appealing buys.

Read more »

Businessperson's Hand Putting Coin In Piggybank
Dividend Stocks

How to Earn $480 in Passive Income With Just $10,000 in Savings

Want to earn some passive income from your savings. Here's how to earn nearly $500 per year from a $10,000…

Read more »

money while you sleep
Investing

Where Will Fairfax Financial Stock Be in 5 Years?

Fairfax Financial Holdings (TSX:FFH) stock looks like a bargain after its latest acquisition!

Read more »